| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0354b89b7906bedb31a6b7bc32adc7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6b15f425d7d4558a7aaffc6752a125e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbac95a54fce6ac622c0c6ca42dff06d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e98b76e011c3ef9d656eeb6fcdddef2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b416a8c0d2b0f1c3d6026d932027af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_304e626dfd0c16bedb8cc39559ca7f76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_803e113c37be7dba07cc334b833a3e68 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate |
2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c85061566af1d1528e6c40f4b49e0dd2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb31bd4b1edc7b61c68482a3a32ff790
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea90d3dc03dc173f516a0cbf70684d1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a6c8a9ec1a1c2005ea841aa29cbea8 |
| publicationDate |
2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012045760-A1 |
| titleOfInvention |
Single Nucleotide Polymorphism Within An Intronic P53 Binding Motif of the Prkag2 Gene |
| abstract |
The present invention relates to single nucleotide polymorphism (SNP). In particular, it relates to a SNP within an intronic p53 binding motif of the PRKAG2. Nucleic acid molecules and methods for aiding assessment of a patient's risk of developing cancer by determining the patient's genotype for a p53 binding motif within the PRKAG2 gene are included in the present invention. |
| priorityDate |
2009-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |